, Volume 47, Issue 1, pp 5–10 | Cite as

Heritable traits that contribute to nephrolithiasis

  • John C. LieskeEmail author
  • Xiangling Wang
Invited Review


Urinary stones tend to cluster in families. Of the known risk factors, evidence is strongest for heritability of urinary calcium excretion. Recent studies suggest that other stone risk factors may have heritable components including urinary pH, citrate and magnesium excretion, and circulating vitamin D concentration. Several risk factors assumed purely environmental may also have heritable components, including dietary intake and thirst. Thus, future studies may reveal that genetics plays an even stronger role in urinary stone pathogenesis than previously known.


Calcium Diet Genetics Urinary stone disease 



Investigators on this study were partially supported by the Rare Kidney Stone Consortium (U54KD083908), a member of the NIH Rare Diseases Clinical Research Network (RDCRN), funded by the NIDDK and the National Center for Advancing Translational Sciences (NCATS); a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (Mayo Clinic O’Brien Urology Research Center: DK100227), and the Mayo Foundation.

Compliance with ethical standards

Conflict of interest

John C Lieske declares that he has no conflict of interest. Xiangling Wang declares that she has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.


  1. 1.
    Ketha H, Singh RJ, Grebe SK, Bergstralh EJ, Rule AD, Lieske JC, Kumar R (2015) Altered calcium and vitamin D homeostasis in first-time calcium kidney stone-formers. PLoS One 10:e0137350Google Scholar
  2. 2.
    Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823Google Scholar
  3. 3.
    Ljunghall S, Danielson BG (1984) A prospective study of renal stone recurrences. Br J Urol 56:122–124Google Scholar
  4. 4.
    Gambaro G, Vezzoli G, Casari G, Rampoldi L, D’Angelo A, Borghi L (2004) Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis 44:963–986Google Scholar
  5. 5.
    Kittanamongkolchai W, Vaughan LE, Enders FT, Dhondup T, Mehta RA, Krambeck AE, McCollough CH, Vrtiska TJ, Lieske JC, Rule AD (2018) The changing incidence and presentation of urinary stones over 3 decades. Mayo Clin Proc 93:291–299Google Scholar
  6. 6.
    Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET (1991) X-linked recessive nephrolithiasis with renal failure. N Engl J Med 325:681–686Google Scholar
  7. 7.
    Worcester EM, Coe FL, Evan AP, Parks JH (2006) Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int 97:1285–1290Google Scholar
  8. 8.
    Rule AD, Bergstralh EJ, Melton LJ 3rd, Li X, Weaver AL, Lieske JC (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4:804–811Google Scholar
  9. 9.
    Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC (2010) Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 21:1641–1644Google Scholar
  10. 10.
    Griffin DG (2004) A review of the heritability of idiopathic nephrolithiasis. J Clin Pathol 57:793–796Google Scholar
  11. 11.
    Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, Gudbjartsson DF, Sulem P, Halldorsson BV, de Vegt F, d’Ancona FC et al (2009) Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41:926–930Google Scholar
  12. 12.
    Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1997) Family history and risk of kidney stones. J Am Soc Nephrol 8:1568–1573Google Scholar
  13. 13.
    Lieske JC, Turner ST, Edeh SN, Smith JA, Kardia SL (2014) Heritability of urinary traits that contribute to nephrolithiasis. Clin J Am Soc Nephrol 9:943–950Google Scholar
  14. 14.
    Trinchieri A, Mandressi A, Luongo P, Coppi F, Pisani E (1988) Familial aggregation of renal calcium stone disease. J Urol 139:478–481Google Scholar
  15. 15.
    Rudan I, Padovan M, Rudan D, Campbell H, Biloglav Z, Janicjevic B, Smolej-Narancic N, Rudan P (2002) Inbreeding and nephrolithiasis in Croatian island isolates. Coll Antropol 26:11–21Google Scholar
  16. 16.
    Sayer JA (2017) Progress in understanding the genetics of calcium-containing nephrolithiasis. J Am Soc Nephrol 28:748–759Google Scholar
  17. 17.
    Parks JH, Coward M, Coe FL (1997) Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 51:894–900Google Scholar
  18. 18.
    Caudarella R, Malavolta N, Rizzoli E, Stefani F, D’Antuono G (1986) Idiopathic calcium urolithiasis: genetic aspects. Ann Med Interne (Paris) 137:200–202Google Scholar
  19. 19.
    Tessier J, Petrucci M, Trouve ML, Valiquette L, Guay G, Ouimet D, Bonnardeaux A (2001) A family-based study of metabolic phenotypes in calcium urolithiasis. Kidney Int 60:1141–1147Google Scholar
  20. 20.
    Loredo-Osti JC, Roslin NM, Tessier J, Fujiwara TM, Morgan K, Bonnardeaux A (2005) Segregation of urine calcium excretion in families ascertained for nephrolithiasis: evidence for a major gene. Kidney Int 68:966–971Google Scholar
  21. 21.
    Monga M, Macias B, Groppo E, Hargens A (2006) Genetic heritability of urinary stone risk in identical twins. J Urol 175:2125–2128Google Scholar
  22. 22.
    Holmes RP, Assimos DG, Goodman HO (1998) Genetic and dietary influences on urinary oxalate excretion. Urol Res 26:195–200Google Scholar
  23. 23.
    Corre T, Olinger E, Harris SE, Traglia M, Ulivi S, Lenarduzzi S, Belge H, Youhanna S, Tokonami N, Bonny O et al (2017) Common variants in CLDN14 are associated with differential excretion of magnesium over calcium in urine. Pflugers Arch 469:91–103Google Scholar
  24. 24.
    Taylor EN, Fung TT, Curhan GC (2009) DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol 20:2253–2259Google Scholar
  25. 25.
    Sorensen MD, Hsi RS, Chi T, Shara N, Wactawski-Wende J, Kahn AJ, Wang H, Hou L, Stoller ML, Women’s Health Initiative Writing G (2014) Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women’s Health Initiative report. J Urol 192:1694–1699Google Scholar
  26. 26.
    Tracy CR, Best S, Bagrodia A, Poindexter JR, Adams-Huet B, Sakhaee K, Maalouf N, Pak CY, Pearle MS (2014) Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. J Urol 192:137–141Google Scholar
  27. 27.
    Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, Soldati L, Gambaro G, Maggiore U, Borghi L (2010) Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr 91:565–570Google Scholar
  28. 28.
    Lieske JC, Tremaine WJ, De Simone C, O’Connor HM, Li X, Bergstralh EJ, Goldfarb DS (2010) Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int 78:1178–1185Google Scholar
  29. 29.
    Goldfarb DS, Coe FL (1999) Beverages, diet, and prevention of kidney stones. Am J Kidney Dis 33:398–400 (discussion 401–393)Google Scholar
  30. 30.
    de Castro JM (1993) Genetic influences on daily intake and meal patterns of humans. Physiol Behav 53:777–782Google Scholar
  31. 31.
    van den Berg L, Henneman P, Willems van Dijk K, Delemarre-van de Waal HA, Oostra BA, van Duijn CM, Janssens AC (2013) Heritability of dietary food intake patterns. Acta Diabetol 50:721–726Google Scholar
  32. 32.
    Lieske JC, Turner ST, Edeh SN, Ware EB, Kardia SL, Smith JA (2016) Heritability of dietary traits that contribute to nephrolithiasis in a cohort of adult sibships. J Nephrol 29:45–51Google Scholar
  33. 33.
    Peacock M (2010) Calcium metabolism in health and disease. Clin J Am Soc Nephrol 5(Suppl 1):S23–S30Google Scholar
  34. 34.
    Assimos DG (2016) Re: altered calcium and vitamin D homeostasis in first-time calcium kidney stone-formers. J Urol 195:658–659Google Scholar
  35. 35.
    Shakhssalim N, Gilani KR, Parvin M, Torbati PM, Kashi AH, Azadvari M, Golestan B, Basiri A (2011) An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors. Urol Res 39:1–7Google Scholar
  36. 36.
    Taylor EN, Hoofnagle AN, Curhan GC (2015) Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones. Clin J Am Soc Nephrol 10:667–675Google Scholar
  37. 37.
    Ferraro PM, Taylor EN, Gambaro G, Curhan GC (2017) Vitamin D intake and the risk of incident kidney stones. J Urol 197:405–410Google Scholar
  38. 38.
    Malihi Z, Wu Z, Stewart AW, Lawes CM, Scragg R (2016) Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis. Am J Clin Nutr 104:1039–1051Google Scholar
  39. 39.
    Wjst M, Altmuller J, Braig C, Bahnweg M, Andre E (2007) A genome-wide linkage scan for 25-OH-D(3) and 1,25-(OH)2-D3 serum levels in asthma families. J Steroid Biochem Mol Biol 103:799–802Google Scholar
  40. 40.
    Engelman CD, Fingerlin TE, Langefeld CD, Hicks PJ, Rich SS, Wagenknecht LE, Bowden DW, Norris JM (2008) Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab 93:3381–3388Google Scholar
  41. 41.
    Karohl C, Su S, Kumari M, Tangpricha V, Veledar E, Vaccarino V, Raggi P (2010) Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr 92:1393–1398Google Scholar
  42. 42.
    Bathum L, Fagnani C, Christiansen L, Christensen K (2004) Heritability of biochemical kidney markers and relation to survival in the elderly—results from a Danish population-based twin study. Clin Chim Acta 349:143–150Google Scholar
  43. 43.
    Whitfield JB, Martin NG (1984) The effects of inheritance on constituents of plasma: a twin study on some biochemical variables. Ann Clin Biochem 21:176–183Google Scholar
  44. 44.
    Hunter DJ, Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD (2002) Genetic contribution to renal function and electrolyte balance: a twin study. Clin Sci (Lond) 103:259–265Google Scholar
  45. 45.
    Moulin F, Ponte B, Pruijm M, Ackermann D, Bouatou Y, Guessous I, Ehret G, Bonny O, Pechere-Bertschi A, Staessen JA et al (2017) A population-based approach to assess the heritability and distribution of renal handling of electrolytes. Kidney Int 92:1536–1543Google Scholar
  46. 46.
    Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J (2015) The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12:295–300Google Scholar
  47. 47.
    Rendina D, De Filippo G, D’Elia L, Strazzullo P (2014) Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol 27:371–376Google Scholar
  48. 48.
    Wong Y, Cook P, Roderick P, Somani BK (2016) Metabolic syndrome and kidney stone disease: a systematic review of literature. J Endourol 30:246–253Google Scholar
  49. 49.
    Mosli HA, Mosli HH, Kamal WK (2013) Kidney stone composition in overweight and obese patients: a preliminary report. Res Rep Urol 5:11–15Google Scholar
  50. 50.
    Lee SC, Kim YJ, Kim TH, Yun SJ, Lee NK, Kim WJ (2008) Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence. J Urol 179:570–574Google Scholar
  51. 51.
    Wang X, Krambeck AE, Williams JC Jr, Tang X, Rule AD, Zhao F, Bergstralh E, Haskic Z, Edeh S, Holmes DR 3rd et al (2014) Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall’s plaque. Clin J Am Soc Nephrol 9:1757–1763Google Scholar
  52. 52.
    Cappuccio FP, Strazzullo P, Mancini M (1990) Kidney stones and hypertension: population based study of an independent clinical association. BMJ 300:1234–1236Google Scholar
  53. 53.
    Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A (1999) Essential arterial hypertension and stone disease. Kidney Int 55:2397–2406Google Scholar
  54. 54.
    Cupisti A, D’Alessandro C, Samoni S, Meola M, Egidi MF (2014) Nephrolithiasis and hypertension: possible links and clinical implications. J Nephrol 27:477–482Google Scholar
  55. 55.
    van Dongen J, Willemsen G, Chen WM, de Geus EJ, Boomsma DI (2013) Heritability of metabolic syndrome traits in a large population-based sample. J Lipid Res 54:2914–2923Google Scholar
  56. 56.
    Maes HH, Neale MC, Eaves LJ (1997) Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27:325–351Google Scholar
  57. 57.
    Elks CE, den Hoed M, Zhao JH, Sharp SJ, Wareham NJ, Loos RJ, Ong KK (2012) Variability in the heritability of body mass index: a systematic review and meta-regression. Front Endocrinol (Lausanne) 3:29Google Scholar
  58. 58.
    Pilia G, Chen WM, Scuteri A, Orru M, Albai G, Dei M, Lai S, Usala G, Lai M, Loi P et al (2006) Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet 2(8):e132Google Scholar
  59. 59.
    Zarkesh M, Daneshpour MS, Faam B, Fallah MS, Hosseinzadeh N, Guity K, Hosseinpanah F, Momenan AA, Azizi F (2012) Heritability of the metabolic syndrome and its components in the Tehran Lipid and Glucose Study (TLGS). Genet Res (Camb) 94:331–337Google Scholar
  60. 60.
    McCarthy JJ (2007) Gene by sex interaction in the etiology of coronary heart disease and the preceding metabolic syndrome. Nutr Metab Cardiovasc Dis 17:153–161Google Scholar
  61. 61.
    Snieder H, van Doornen LJ, Boomsma DI (1997) The age dependency of gene expression for plasma lipids, lipoproteins, and apolipoproteins. Am J Hum Genet 60:638–650Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Nephrology and HypertensionMayo ClinicRochesterUSA
  2. 2.Department of Laboratory Medicine and PathologyMayo ClinicRochesterUSA
  3. 3.Genomic Medicine Institute, Department of Nephrology and Hypertension, Lerner Research InstituteCleveland ClinicClevelandUSA

Personalised recommendations